Beijing Medical University Orders China's First Molecular Coincidence Camera From ADAC.MILPITAS, Calif.--(BW HealthWire)--July 8, 1998--ADAC Laboratories (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ADAC ADAC Allgemeiner Deutscher Automobil Club (German automobile club) ADAC Aboriginal Drug and Alcohol Council ADAC Art Directors and Artists Club (Sacramento, California) ADAC Alcohol and Drug Abuse Council ), the world market share leader in nuclear medicine and radiation therapy planning systems, announced today that it has received a contract for China's first Molecular Coincidence Detection camera with Attenuation Loss of signal power in a transmission. Attenuation The reduction in level of a transmitted quantity as a function of a parameter, usually distance. It is applied mainly to acoustic or electromagnetic waves and is expressed as the ratio of power densities. Correction (MCD/AC(TM)) from the Beijing Medical University Affiliated Hospital. Beijing Medical University Affiliated Hospital is a pioneering 1,000 bed general practice hospital as well as a teaching hospital associated with the University of Beijing Medical School. It is one of the most respected and influential medical centers in China. ADAC's MCD technology allows its nuclear medicine imaging nuclear medicine imaging, n the diagnostic imaging field that evaluates organ function by injecting isotopes into a structure and documenting the amount of radiation emanating from the tissues. systems to perform both Single Photon Emission Computed Tomography single photon emission computed tomography n. Abbr. SPECT Tomographic imaging of local metabolic and physiological functions in tissues. ("SPECT SPECT single-photon emission computed tomography. SPECT abbr. single photon emission computed tomography SPECT, n See single photon emission computer tomography. ") and coincidence imaging previously available only on dedicated Positron Emission Tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. ("PET") imaging systems. MCD/AC is an enhancement to the MCD system that corrects for image distortions created by soft tissue in the human body. Dr. Lin, Chief Nuclear Medicine Physician of Beijing Medical University Affiliated Hospital, commented, "In China, most of the hospitals are not able to afford the dedicated PET scanner system. In addition, the purchase of the dedicated PET scanner system requires a special import quota from the China Central Government. We believe that the ADAC MCD/AC gamma camera will help us make ADAC's PET-FDG imaging more popular and common in China. Consequently, it will raise the medical service standard for the whole community." Tim Henning, Senior Vice President Global Operations, stated, "We are very excited about the opportunity to work with such an influential institution. This marks a major milestone in our commitment to the China market and the opportunity to bring MCD technology to such a large patient population. The market potential for this technology appears to be quite significant." ADAC Laboratories is the world market share leader in nuclear medicine and radiation therapy planning systems, and a leading supplier of radiology information systems. In 1996, ADAC became the first healthcare manufacturer to receive a Malcolm Baldrige National Quality Award The Malcolm Baldrige National Quality Award is given by the United States National Institute of Standards and Technology. Through the actions of the National Productivity Advisory Committee chaired by Jack Grayson, it was established by the Malcolm Baldrige National Quality . ADAC is headquartered in Milpitas, CA., with its HealthCare Information Systems division in Houston, TX. This press release contains forward looking statements. Factors that could cause actual results to differ materially from those contained in such forward looking statements include those factors set forth under "Business Considerations" in the company's most recent Annual Report on Form 10-Q. All forward looking statements are based on information available to the company on the date hereof, and the company assumes no obligation to update such statements.
CONTACT: ADAC Laboratories (Director of IR)
Jenny D. Lee, 408/321-9100
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion